Changes in serum lipids when fluvastatin is substituted for lovastatin in the same doses

American Journal of Cardiology

Volumn 80, Issue 3, 1997, Pages 348-349

  Rindone, Joseph P ^a   Arriola, Greg ^a   Hiller, Debra ^a   Achacoso, Rolando ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUINDOSTATIN; MEVINOLIN;

ADULT; AGED; ARTICLE; CHOLESTEROL METABOLISM; DOSE CALCULATION; DRUG EFFICACY; HUMAN; HYPERCHOLESTEROLEMIA; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AGED; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; FATTY ACIDS, MONOUNSATURATED; HUMANS; INDOLES; LIPOPROTEINS; LOVASTATIN; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRIGLYCERIDES;

EID: 0030877714     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(97)00361-5     Document Type: Article

References (4)

1. Choice of lipid-lowering drugs. The Medical Letter. 38:1996;67-70.
2. Zavoral JH, Haggerty DJ, Winick AG, Bergmann SD. Efficacy of fluvastatin; a totally synthetic 3-hydroxy-3- methyglutaryl coenzyme A reductase inhibitor. Fluent Study Group. Fluvastatin long-term extension trial. Am J Cardiol. 76:1995;37A-40A.
3. Bradford RH, Shear CL, Chremos AN, Dujovne C, Downton M, Franklin FA, Gould AC, Hesney M, Higgins J, Hurley DP, Langendorfer A, Nash DT, Pool JL, Schnaper H. Expanded elinical evaluation of lovastatin (EXCEL) study results. Efficacy in modifying plasma lipoprotein and adverse event profile in 8245 patients with moderate hypercholesterolemia. Arch Intern Med. 151:1991;43-49.
4. Berger ML, Wilson HM, Liss CL. A comparison of the tolerability and efficacy of lovastatin 20 mg and fluvastatin 20 mg in the treatment of primary hypercholesterolemia. J Cardiovasc Pharmacol Ther. 1:1996;101-106.